Dr. Trudy H Sanson, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 102 Thomas Rd, Suite 206, West Monroe, LA 71291 Phone: 318-387-0641 Fax: 318-387-0645 |
News Archive
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
Tribune Newspapers/Chicago Tribune reports that a new partnership between UnitedHealth Group Inc. and the National Restaurant Association aims "to make coverage more accessible to millions of restaurant workers without health benefits, three years ahead of when the health care overhaul would require everyone to have insurance."
Atlanta Falcons Defensive End Chauncey Davis recently honored Georgia Power Foundation's Michael Anderson, Aetna's Cynthia Follmer and Camp Kudzu- Georgia's largest camp for kids with diabetes, during the 2009 Community Impact Awards, at the Arthur Blank Family Office.
More people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours (nights and weekends), compared with patients who arrive during regular daily hours, according to a Mayo Clinic study published online in the British Medical Journal on Jan. 21.
› Verified 5 days ago